ACI's Anti-Corruption for the Life Sciences Industry Conference
In response to the unique challenges facing biopharmaceutical and medical device companies in this daunting enforcement climate, the 8th National Conference on FCPA & Anti-Corruption for the Life Sciences Industry provides a forum for the key players - top federal prosecutors, preeminent corporate counsel, and leading FCPA practitioners - to come together for critical networking and benchmarking on how to combat the next wave of FCPA allegations.
U.S. and foreign prosecutors are using all the tools at their disposal to ensure that FCPA and anti-corruption violations by medical device and biotech and pharmaceutical companies are brought to light and punished. Do not miss your chance to be part of the most comprehensive, industry-tailored forum on innovative solutions for protecting your company before, during, and after the government comes knocking.
Paul Hastings partner Nathaniel Edmonds is a featured panelist during the DOJ and SEC Alumni Roundtable Discussion.
For additional information and to regisiter, visit the